Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice

Huangqi Decoction Alleviates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis by Reversing Disordered Bile Acid and Glutathione Homeostasis in Mice

Intrahepatic cholestasis is a serious symptom of liver disorders with limited therapies. In this study, we investigated the efficacy of Huangqi decoction (HQD), a two-herb classic traditional Chinese medicine (TCM), in the treatment of alpha-naphthylisothiocyanate (ANIT)-induced intrahepatic cholest...

Full description

Bibliographic Details
Main Authors:	Jia-Sheng Wu, Yi-Fei Li, Yuan-Yuan Li, Yan Dai, Wen-Kai Li, Min Zheng, Zheng-Chun Shi, Rong Shi, Tian-Ming Wang, Bing-Liang Ma, Ping Liu, Yue-Ming Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-12-01
Series:	Frontiers in Pharmacology
Subjects:	intrahepatic cholestasis Huangqi decoction traditional Chinese medicine Nrf2 metabolomics
Online Access:	http://journal.frontiersin.org/article/10.3389/fphar.2017.00938/full

Similar Items

Yinchenhao Decoction Ameliorates Alpha-Naphthylisothiocyanate Induced Intrahepatic Cholestasis in Rats by Regulating Phase II Metabolic Enzymes and Transporters
by: Ya-Xiong Yi, et al.
Published: (2018-05-01)

Targeted bile acid profiles reveal the liver injury amelioration of Da-Chai-Hu decoction against ANIT- and BDL-induced cholestasis
by: YueHua Zhou, et al.
Published: (2022-08-01)

Bile Acids in Intrahepatic Cholestasis of Pregnancy
by: Maciej Majsterek, et al.
Published: (2022-11-01)

Improvement of Huangqi Decoction on Endothelial Dysfunction in 5/6 Nephrectomized Rats
by: Shuang Chu, et al.
Published: (2016-12-01)

BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS (BRIC)
by: S. Arulprakash, et al.
Published: (2010-03-01)

An exploratory study on the mechanism of Huangqi Guizhi Wuwu Decoction in the treatment of neuropathic pain
by: Bo‐Yan Luo, et al.
Published: (2022-06-01)

Effect of Fufang Huangqi Decoction on the Gut Microbiota in Patients With Class I or II Myasthenia Gravis
by: Yanghong Chen, et al.
Published: (2022-03-01)

Intrahepatic cholestasis of pregnancy: Prevalence and perinatal outcome
by: R Bassi, et al.
Published: (2012-01-01)

Insights into the molecular mechanisms of Huangqi decoction on liver fibrosis via computational systems pharmacology approaches
by: Biting Wang, et al.
Published: (2021-07-01)

"An Iranian girl with benign recurrent intrahepatic cholestasis "
by: Kavehmanesh Z, et al.
Published: (2002-03-01)

Sepsis as a cause of intrahepatic cholestasis
by: Rudić Jelena, et al.
Published: (2009-01-01)

Modified Huangqi Chifeng Decoction Attenuates Proteinuria by Reducing Podocyte Injury in a Rat Model of Immunoglobulin a Nephropathy
by: Meiying Chang, et al.
Published: (2021-07-01)

Huangqi-Danshen decoction protects against cisplatin-induced acute kidney injury in mice
by: Xinhui Liu, et al.
Published: (2023-11-01)

HuangQi Decoction Improves Renal Tubulointerstitial Fibrosis in Mice by Inhibiting the Up-Regulation of Wnt/β-Catenin Signaling Pathway
by: Ming-Qian Jiang, et al.
Published: (2015-05-01)

Molecular mechanisms of transporter regulation and their impairment in intrahepatic cholestasis
by: Xiping Li, et al.
Published: (2022-10-01)

HuangQi Decoction Ameliorates Renal Fibrosis via TGF-β/Smad Signaling Pathway In Vivo and In Vitro
by: Jie Zhao, et al.
Published: (2016-05-01)

Huangqi Guizhi Wuwu Decoction Improves Arthritis and Pathological Damage of Heart and Lung in TNF-Tg Mice
by: Yi Wang, et al.
Published: (2022-05-01)

Mechanism of Huangqi Jianzhong Decoction in Treating Diarrhea Predominant Irritable Bowel Syndrome Based on Network Pharmacology and Molecular Docking Technology
by: Kun YE, Min LEI, Xin XIE, Hui ZHENG, Min CHEN, Shuguang YU
Published: (2022-05-01)

Huangqi decoction ameliorates kidney injury in db/db mice by regulating the BMP/Smad signaling pathway
by: Ying Chen, et al.
Published: (2023-06-01)

Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
by: Yinxiao Jiang, et al.
Published: (2021-11-01)

Assessment of vitamin K levels in women with intrahepatic cholestasis of pregnancy
by: Maria Cemortan, et al.
Published: (2022-07-01)

B-lymphoblastic leukaemia presenting as intrahepatic cholestasis
by: Daniyal Raza, et al.
Published: (2023-10-01)

Congenital thrombophilia associated with intrahepatic cholestasis of pregnancy. A case report
by: Corina Iliadi-Tulbure, et al.
Published: (2022-08-01)

A Prospective, Randomized, Placebo-Controlled Study Assessing the Efficacy of Chinese Herbal Medicine (Huangqi Guizhi Wuwu Decoction) in the Treatment of Albumin-Bound Paclitaxel-Induced Peripheral Neuropathy
by: Yue Chai, et al.
Published: (2023-01-01)

Huangqi Guizhi Wuwu decoction alleviates oxaliplatin-induced peripheral neuropathy via the gut-peripheral nerve axis
by: Zhengwei Zhang, et al.
Published: (2023-09-01)

Are Postprandial Bile Acid Levels Helpful in Predicting Perinatal Complications in Patients with Intrahepatic Cholestasis of Pregnancy?
by: Kudret Erkenekli, et al.
Published: (2015-06-01)

Placental Expression of Bile Acid Transporters in Intrahepatic Cholestasis of Pregnancy
by: Edgar Ontsouka, et al.
Published: (2021-09-01)

Herbal formula Huangqi Guizhi Wuwu decoction attenuates paclitaxel-related neurotoxicity via inhibition of inflammation and oxidative stress
by: Zhangming Lv, et al.
Published: (2021-08-01)

Seasonal Impact in the Frequency of Intrahepatic Cholestasis of Pregnancy
by: Cem Yaşar Sanhal, et al.
Published: (2016-04-01)

Exploration of the mechanism by which Huangqi Guizhi Wuwu decoction inhibits Lps-induced inflammation by regulating macrophage polarization based on network pharmacology
by: Sutong Wang, et al.
Published: (2023-01-01)

EVALUATION OF RISK FACTORS FOR INTRAHEPATIC CHOLESTASIS OF PREGNANCY IN PATIENTS PRESENTING TO A TERTIARY CARE CENTRE
by: Rabiah Anwar, et al.
Published: (2021-10-01)

A Rare Case of Recurrent Intrahepatic Cholestasis of Pregnancy With Prolonged Postpartum Hepatic Inflammation Despite Normalization of Bile Acid Levels
by: Pir Ahmad Shah, et al.
Published: (2023-01-01)

Efficacy and safety of low-dose rifampicin in patients with benign intrahepatic cholestasis
by: Xiaoyan Guo, et al.
Published: (2022-09-01)

HuangqiGuizhiWuwu Decoction Prevents Vascular Dysfunction in Diabetes via Inhibition of Endothelial Arginase 1
by: Hong Cheng, et al.
Published: (2020-03-01)

Screening of the key response component groups and mechanism verification of Huangqi-Guizhi-Wuwu-Decoction in treating rheumatoid arthritis based on a novel computational pharmacological model
by: Qinwen Liu, et al.
Published: (2024-01-01)

The use of metformin in the treatment of Intrahepatic cholestasis of pregnancy
by: Paulina Pawłowska, et al.
Published: (2022-09-01)

Achieving Consensus in the Management of Intrahepatic Cholestasis in Pregnancy
by: Julianna Briglio, et al.
Published: (2017-06-01)

Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood
by: Fatih Ermis, MD, et al.
Published: (2010-04-01)

Erratum: HuangqiGuizhiWuwu Decoction Prevents Vascular Dysfunction in Diabetes via Inhibition of Endothelial Arginase 1
by: Frontiers Production Office
Published: (2021-01-01)

Metabolomics Analysis Reveals the Protection Mechanism of Huangqi–Danshen Decoction on Adenine-Induced Chronic Kidney Disease in Rats
by: Xinhui Liu, et al.
Published: (2019-09-01)